StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd

Bullboard Posts

Comment by Str8Shooter88on Apr 12, 2016 5:25pm

66 Views

Post# 24758841

RE:RE:RE:Financing at 0.10c is not really a good news and

ServoTech wrote:

Str8Shooter88 wrote:

Jango4ever wrote: the question is how many million of warrants at 0.01c must be exercised? this is the problem and the sp mathematically has to comply and go down around 0.04c before heading up to 0.10 if very good nes are posted in the future.

WTF are you even talking about? On ignore you go. It isn't going down to .04cents let alone .10 again. I sure hope (for your sake) you are joking.

Jango admitted having placed these posts on the WRONG BOARD.
Come on, cut him a little slack.